Report on Gavi Talks with Civil Society Session 3: CSO-led Advocacy and Community Action in Scaling the Malaria Vaccine
Introduction
This report captures the discussions and insights from a session on CSO-led Advocacy and Community Action in Scaling the Malaria Vaccine. The session focused on the role of Civil Society Organizations (CSOs) in rolling out the malaria vaccine across African countries, particularly in Ghana, Kenya, Malawi, and Cameroon. The panel included representatives from various countries and health organizations who discussed community engagement strategies, key challenges, and the successes achieved through collaborative efforts.
Overview
The malaria vaccine represents a major milestone in the fight against malaria, one of the leading causes of child mortality in Africa. The pilot introduction of the vaccine began in 2019 in Ghana, Kenya, and Malawi. As of early 2024, the rollout had expanded to nine additional countries, including Cameroon. During the session, Dr. Scott Gordon, the Head of the Malaria Vaccine Program at Gavi, provided an overview of this progress. He emphasized that CSOs are crucial in creating awareness about the malaria vaccine, particularly since it has a different schedule compared to other routine childhood vaccinations.
Dr. Gordon remarked, “CSOs play an incredibly important role in all aspects of health, and their engagement is essential for the success of the malaria vaccine introduction.” The vaccine targets children under five and requires four doses to be fully effective, making community mobilization critical to ensure parents bring their children in for all necessary doses.
Chapters
CSO Contributions and Community Engagement
1. Collaborative Efforts
· Malawi’s Success Story: In Malawi, the collaboration between the Ministry of Health, CSOs, and other partners like the Malawi Health Equity Network (MHEN) was essential for a successful rollout. Hannah Hausey, a Senior Immunization Technical Advisor from Malawi, shared that CSOs not only helped mobilize financial resources but also played a critical role in community-level engagement, ensuring that the vaccination program reached even remote areas. The use of mother care groups, who went door-to-door to monitor children’s vaccination statuses, significantly improved coverage. Hannah Hausey explained, “These women played a critical role, revising their tools to ensure that malaria vaccines were included, which helped improve the uptake for doses one, two, and three.”
· Community Mobilization in Cameroon: In Cameroon, Dr. Bizong, the Regional Technical Coordinator for the Fight Against Malaria, shared that CSOs worked closely with government health programs to support vaccine rollout, especially in hard-to-reach and conflict-affected regions. The partnership with faith-based organizations
like the Cameroon Baptist Convention Health Services ensured the vaccine reached communities that were otherwise difficult to access. Dr. Bizong noted, “The collaboration between the malaria program and expanded immunization programs improved our reach into these communities, ensuring they were informed and motivated to bring their children for vaccination.”
2. Communication and Behavioral Change
· Addressing Misinformation: Across both Malawi and Cameroon, one of the greatest challenges was misinformation. After COVID-19, many communities believed that the malaria vaccine was linked to the COVID vaccine, which hindered initial uptake. Dr. Gordon explained that CSOs played a vital role in dispelling these rumors and promoting accurate information about the vaccine’s safety and efficacy.
· Strategic Communication in Malawi: Malawi employed interpersonal communication strategies, using trusted local leaders to relay messages about the importance of the vaccine. However, Hannah Hausey noted that due to limited resources, the program could not rely on mass media. This made reaching every community a slow and arduous process. The CSOs’ work with local care groups became even more essential in this context.
3. Reaching Hard-to-Reach Communities
Dr. Eugene, from Cameroon Baptist Convention Health Services, highlighted the work of CSOs in conflict-affected and remote areas. Through close collaboration with community leaders and local churches, CSOs ensured vaccine accessibility in fragile districts, where healthcare infrastructure was limited. Dr. Eugene explained: “We know where the children are, and through close engagement with religious leaders and community groups, we ensured that these communities were not left behind.”
Key Challenges in Scaling the Malaria Vaccine
1. Dropout Rates and Loss of Health Profiles
· In both Malawi and Cameroon, dropout rates between the first and fourth doses of the malaria vaccine were alarmingly high. In Cameroon, Dr. Andreas shared that the dropout rate from the first to the third dose was over 50%, with many children failing to receive the fourth dose. Similarly, Malawi struggled to ensure that children returned for the later doses. Hannah Hausey cited challenges with caregivers losing
child health profiles, which made it difficult to track vaccination statuses. Dr. Andreas noted: “One of the biggest hurdles has been maintaining the momentum from the first dose to the fourth, especially since the fourth dose is administered at 22 months, outside the typical first-year vaccination schedule.”
2. Vaccine Supply and Equity
· Initially, vaccine supply limitations meant that only select districts in high-prevalence areas could receive the malaria vaccine. Dr. Gordon explained that, as vaccine supplies have increased, countries like Malawi are now planning to expand the vaccine to additional districts. This expansion is critical for achieving vaccine equity.
· Resource Mobilization: Both Malawi and Cameroon faced challenges with securing enough funding to implement widespread communication and community engagement strategies. Hannah Hausey mentioned that there were “too few CSOs engaged to provide support for the malaria vaccine, and this limited the reach of community mobilization efforts.”
3. Second-Year Life Immunization
· The malaria vaccine’s fourth dose is administered at 22 months, which falls outside the traditional first-year immunization schedule. This has proven challenging, as many caregivers do not return to health centers after the child’s first year. CSOs have worked to close this gap by emphasizing the importance of all four doses in community outreach campaigns.
Practical Recommendations for Improvement
1. Strengthen CSO-Government Collaboration
CSOs must continue working closely with Ministries of Health to address coverage gaps, especially in remote areas. Dr. Eugene highlighted the importance of working together from the planning stage: “We need inclusive engagement that reflects the needs and realities of the communities.”
2. Integrated Health Services
CSOs and governments should work to integrate malaria vaccines with other health services, such as nutrition programs and growth monitoring, to ensure regular contact
between caregivers and health workers. Dr. Gordon suggested aligning vaccination touchpoints with other health services, such as vitamin A distribution and early childhood screenings, to encourage parents to bring their children back to health centers.
3. Addressing the Dropout Rate
To address the significant dropout rate, CSOs should enhance follow-up mechanisms, using digital tools such as SMS reminders and setting up community tracking systems. Community leaders should also organize fixed vaccination days at accessible locations like markets or churches to make the process more convenient for caregivers.
4. Continuous Funding for CSO-led Initiatives
Increased funding is essential for CSOs to continue their work in educating and mobilizing communities. More financial support would allow CSOs to scale their operations and reach more remote areas.
5. Engage Women and Religious Groups
CSOs should continue leveraging women’s groups and religious organizations to engage communities. Women’s care groups in Malawi proved effective in promoting vaccination uptake, while faith-based organizations in Cameroon were instrumental in accessing conflict-affected regions.
Conclusion
The introduction of the malaria vaccine across Africa marks a significant step in the global fight against malaria. However, the success of the rollout depends heavily on community engagement, communication, and sustained collaboration between CSOs and governments. CSOs have been at the forefront of these efforts, addressing challenges, mobilizing communities, and ensuring vaccine equity.
Moving forward, increased funding, stronger CSO-government collaboration, and integrated health services will be critical to ensuring the malaria vaccine reaches all children in need, especially in hard-to-reach areas. As Dr. Scott Gordon emphasized, “CSOs will continue to play a critical role in ensuring that no child is left behind in the fight against malaria.”